Rheumatoid Arthritis Clinical Trials in Los Angeles

Showing 781-800 of 3,190 trials

Ultrasound Stimulation for Patients in a Disorder of Consciousness

NCT06939348

The overall aim of this study is to develop an intervention that can help recovery in patients surviving severe brain injury but failing to fully recover. In particular, this multicenter project aims to (1) establish short-term efficacy of tFUS as a therapeutic to promote recovery in patients with prolonged DoC as compared to sham treatment, (2) establish dose-related safety and efficacy of tFUS as a therapeutic intervention in prolonged DoC patients and (3) explore preliminary predictors and biomarkers of susceptibility and response to thalamic sonication.

Consciousness DisordersDisorders of Consciousness Due to Severe Brain Injury

University of California, Los Angeles60 participantsStarted Apr 2025

Los Angeles, California, United States • Pomona, California, United States • Boston, Massachusetts, United States +1 more locations

COMPLETEDPhase 1/2< 1 mile

A Phase 1/2 Study of CPI-0610 With and Without Ruxolitinib in Patients With Hematologic and Myeloproliferative Malignancies

NCT02158858

Phase 1 Part: Open-label, sequential dose escalation study of pelabresib (CPI-0610) in patients with previously treated Acute Leukemia, Myelodysplastic/Myeloproliferative Neoplasms, and Phase 2 Part: Open-label study of pelabresib (CPI-0610) with and without Ruxolitinib in patients with Myeloproliferative Neoplasms (Myelofibrosis and Essential Thrombocythemia). Pelabresib (CPI-0610) is a small molecule inhibitor of bromodomain and extra-terminal (BET) proteins.

MyelofibrosisLeukemia, Myelocytic, AcuteMyelodysplastic/Myeloproliferative Neoplasm+11 more

Constellation Pharmaceuticals336 participantsStarted Jul 2014

Phoenix, Arizona, United States • Los Angeles, California, United States • Jacksonville, Florida, United States +45 more locations

Ultrasound Stimulation for Patients in a Disorder of Consciousness

A Phase 1/2 Study of CPI-0610 With and Without Ruxolitinib in Patients With Hematologic and Myeloproliferative Malignancies

Rheumatoid Arthritis Trials in Other Cities

P-15L Bone Graft in Transforaminal Lumbar Interbody Fusion With Instrumentation

Lactobacillus Plantarum in Preventing Acute Graft Versus Host Disease in Children Undergoing Donor Stem Cell Transplant

CBX-12 for the Treatment of Metastatic Chemotherapy-Refractory Microsatellite Stable Colorectal Cancer

A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Lacosamide in Neonates With Repeated Electroencephalographic Neonatal Seizures

A Dose-ranging Study in Patients With Diabetic Peripheral Neuropathic Pain (DPNP)

A Clinical Study That Will Measure How Well SEP-363856 Works and How Safe it is in Adults With Generalized Anxiety Disorder

Testing the Addition of an Anti-cancer Immune Therapy Drug (Nivolumab) to the Usual Chemotherapy Treatment (Cisplatin or Carboplatin With Gemcitabine) for Recurrent or Metastatic Nasopharyngeal Cancer

Safety and Efficacy Trial of MTX101 2mg for the Acute Treatment of Migraine in Adults

MiRisten for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia

Cellular Immunotherapy Following Chemotherapy in Treating Patients With Recurrent Non-Hodgkin Lymphomas, Chronic Lymphocytic Leukemia, or B-Cell Prolymphocytic Leukemia

Genetically Modified T-cell Infusion Following Peripheral Blood Stem Cell Transplant in Treating Patients With Recurrent or High-Risk Non-Hodgkin Lymphoma

Pilot Study on Pairing Sedation Strategies and Weaning

Study of Selinexor in Combination With Backbone Treatments or Novel Therapies In Participants With Relapsed or Refractory (RR) Diffuse Large B-Cell Lymphoma (DLBCL)

An Open-Label Extension Study of BPN14770 in Subjects With Fragile X Syndrome

A Study to Assess the Safety, Tolerability, and Effect on Disease Progression of BIIB105 in Participants With Amyotrophic Lateral Sclerosis (ALS) and Participants With the ALS Ataxin-2 (ATXN2) Genetic Mutation

Improving Outcomes Assessment in Chronic GVHD

Post-Surgical Stereotactic Radiotherapy (SRT) Versus GammaTile-ROADS (Radiation One and Done Study)

A Study of AC676 for the Treatment of Relapsed/Refractory B-Cell Malignancies

Other Conditions in Los Angeles